Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 3—March 2010
Research

Economic Cost Analysis of West Nile Virus Outbreak, Sacramento County, California, USA, 2005

Loren M. Barber, Jerome J. Schleier, and Robert K.D. PetersonComments to Author 
Author affiliations: Montana State University, Bozeman, Montana, USA

Main Article

Table 2

Estimated inpatient and outpatient economic costs of WNND cases, Sacramento County, California, 2005*

Item
 Cost per case†
 No. cases to which cost applies‡
 % Cases to which cost applies§
 Total cost for all cases
 Total cost if treatment/service were used in all cases
Inpatient treatment costs $33,143 46 100 $1,524,570 $1,524,570
Outpatient costs Cost per case¶
Outpatient hospital treatment $333 17 36 $5,668 $15,337
Physician visits $450 46 100 $20,708 $20,708
Outpatient physical therapy $909 46 100 $41,810 $41,810
Occupational therapy $4,037 3 7 $12,111 $185,699
Speech therapy $588 1 1 $588 $27,032
Total
$80,885
 $290,586
Nursing home costs Cost#
Nursing home stay** $190 2 4 $36,195 $36,195
Transportation $65 46 100 $2,977 $2,977
Home health aides, babysitters, etc. $1,569 7 14 $10,983 $505,211
Total
$50,154
 $544,383
Total for WNND $2,140,409 $2,844,339

*WNND, West Nile neuroinvasive disease; BLS, Bureau of Labor Statistics of the US Department of Labor.
†Estimated by using 2005 data from California’s Office of Statewide Health Planning and Development (J. Teague and J. Morgan, pers. comm.).
‡WNND cases from the total number of cases reported by the Centers for Disease Control and Prevention (3).
§See (10).
¶Estimated by using data from Zohrabian et al. (10) and updated using data from the US Department of Labor’s Bureau of Labor Statistics (BLS) (13–15).
#Estimated by using data from MetLife Mature Market Institute (16), Zohrabian et al. (10), and BLS (13–15).
**Average length of nursing home stay was 96 days.

Main Article

References
  1. California Department of Health Services. Division of Communicable Disease Control. West Nile activity in California, 2005 [cited 2008 Nov 28]. http://www.westnile.ca.gov/reports.php?report_category_id=8
  2. California Department of Public Health. Mosquito and Vector Control Association of California; University of California. California mosquito-borne virus surveillance and response plan [cited 2008 Nov 28]. http://www.westnile.ca.gov/resources.php
  3. Centers for Disease Control and Prevention. Human West Nile virus (WNV) cases in California, 2005 (reported as of 03/30/2006) [cited 2008 Nov 5]. http://www.westnile.ca.gov/website/maps_data/2005_maps_data/2005%20Human%20WNV%20Case%20Linelist.pdf
  4. Marfin  AA, Gubler  DJ. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis. 2001;33:1713–9. DOIPubMedGoogle Scholar
  5. Elnaiem  DE, Kelley  K, Wright  S, Laffey  R, Yoshimura  G, Reed  M, Impact of aerial spraying of pyrethrin insecticide on Culex pipiens and Culex tarsalis (Diptera: Culicidae) abundance and West Nile virus infection rates in an urban/suburban area of Sacramento County, California. J Med Entomol. 2008;45:751–7. DOIPubMedGoogle Scholar
  6. Carney  RM, Husted  S, Jean  C, Glaser  C, Kramer  V. Efficacy of aerial spraying of mosquito adulticide in reducing incidence of West Nile virus, California, 2005. Emerg Infect Dis. 2008;14:747–54. DOIPubMedGoogle Scholar
  7. Centers for Disease Control and Prevention. West Nile virus: clinical description [cited 2008 Dec 15]. http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/clindesc.htm#diag
  8. Petersen  LR, Martin  AA, Gubler  DJ. West Nile virus. JAMA. 2003;290:524–8. DOIPubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. West Nile virus: media facts [cited 2009 Mar 23]. http://www.cdc.gov/ncidod/dvbid/westnile/resources/FightTheBite_FactSheet/MediaTools/print/WNV%20media%20factsheet_natnl.pdf
  10. Zohrabian  A, Meltzer  MI, Ratard  R, Billah  K, Molinari  NA, Roy  K, West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis. 2004;10:1736–44.PubMedGoogle Scholar
  11. Zohrabian  A, Hayes  EB, Petersen  LR. Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis. 2006;12:375–80.PubMedGoogle Scholar
  12. State of California Department of Industrial Regulations. California code of regulations. Title 8, CCR §9789.23. Hospital cost to charge ratios, hospital specific outliers, and hospital composite factors [cited 2010 Jan 15]. http://www.dir.ca.gov/dwc/OMFS_Inpatient/OMFS_Inpatient_table9789_23.pdf
  13. Bureau of Labor Statistics, US Department of Labor. Consumer Price Index, 2003 [cited 2010 Jan 15]. http://www.bls.gov/cpi/cpid03av.pdf
  14. Bureau of Labor Statistics, US Department of Labor. Consumer Price Index, 2004 [cited 2010 Jan 15]. http://www.bls.gov/cpi/cpid04av.pdf
  15. Bureau of Labor Statistics, US Department of Labor. Consumer Price Index, 2005 [cited 2010 Jan 15]. http://www.bls.gov/cpi/cpid05av.pdf
  16. MetLife Mature Market Institute. MetLife, Inc. The MetLife market survey of nursing home and home care costs [cited 2008 Nov 6]. http://www.metlife.com/WPSAssets/41453139101127828650V1F2005%20NH%20and%20HC%20Market%20Survey.pdf
  17. Bureau of Labor Statistics, US Department of Labor. Sacramento–Yolo, CA, National Compensation Survey, July 2005. Bulletin 3130–48 [cited 2008 Nov 8]. http://www.bls.gov/ncs/ocs/sp/ncbl0789.pdf
  18. Grosse  SD. Appendix I. Productivity loss tables. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness, 2nd ed. New York: Oxford University Press; 2003. p. 255–7.
  19. Brown  E, Beauregard  K. Statistical brief #157. Regional differences in total and out-of-pocket expenditures for selected types of office-based visits, 2004. Rockville (MD): Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality; 2007 [cited 2010 Jan 15]. http://www.meps.ahrq.gov/mepsweb/data_files/publications/st157/stat157.pdf
  20. Palmisano  CT, Taylor  V, Caillouet  K, Byrd  B, Wesson  DM. Impact of West Nile virus outbreak upon St. Tammany Parish mosquito abatement district. J Am Mosq Control Assoc. 2005;21:33–8. DOIPubMedGoogle Scholar
  21. Simpson  JE. Emergency mosquito aerial spray response to the 2004 Florida hurricanes Charley, Frances, Ivan, and Jeanne: an overview of control results. J Am Mosq Control Assoc. 2006;22:457–63. DOIPubMedGoogle Scholar
  22. Centers for Disease Control and Prevention. Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. Reported as of 2003 Aug. Fort Collins (CO): The Centers; 2003 [cited 2009 Mar 23]. http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnv-guidelines-aug-2003.pdf
  23. Peleman  RA. New and re-emerging infectious diseases: epidemics in waiting. Curr Opin Anaesthesiol. 2004;17:265–70. DOIPubMedGoogle Scholar
  24. Antwi  FB, Shama  LM, Peterson  RKD. Risk assessments for the insect repellents DEET and picaridin. Regul Toxicol Pharmacol. 2008;51:31–6. DOIPubMedGoogle Scholar
  25. John  KH, Stoll  JR, Olson  JK. An economic assessment of the benefits of mosquito abatement in an organized mosquito control district. J Am Mosq Control Assoc. 1987;3:8–14.PubMedGoogle Scholar
  26. Busch  MP, Wright  DJ, Custer  B, Tobler  LH, Stramer  SL, Kleinman  SH, West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395–402.PubMedGoogle Scholar
  27. Peterson  RK, Macedo  PA, Davis  RS. A human-health risk assessment for West Nile virus and insecticides used in mosquito management. Environ Health Perspect. 2006;114:366–72. DOIPubMedGoogle Scholar
  28. Davis  RS, Peterson  RK, Macedo  PA. An ecological risk assessment for insecticides used in adult mosquito management. Integr Environ Assess Manag. 2007;3:373–82. DOIPubMedGoogle Scholar
  29. Schleier  JJ III, Macedo  PA, Davis  RS, Shama  LM, Peterson  RKD. A two-dimensional probabilistic acute human-health risk assessment of insecticide exposure after adult mosquito management. Stochastic Environ Res Risk Assess. 2009;23:555–63. DOIGoogle Scholar
  30. Schleier  JJ III, Davis  RS, Barber  LM, Macedo  PA, Peterson  RK. A probabilistic risk assessment for deployed military personnel after the implementation of the “Leishmaniasis Control Program” at Tallil Air Base, Iraq. J Med Entomol. 2009;46:693–702. DOIPubMedGoogle Scholar
  31. Schleier  JJ III, Peterson  RK, Macedo  PA, Brown  DA. Environmental concentrations, fate, and risk assessment of pyrethrins and piperonyl butoxide after aerial ultralow-volume applications for adult mosquito management. Environ Toxicol Chem. 2008;27:1063–8. DOIPubMedGoogle Scholar
  32. Suffolk County Department of Public Works and Department of Health Services. Draft generic environmental impact statement [cited 2009 Mar 1]. http://www.suffolkmosquitocontrolplan.org/tasks/task14.html
  33. Carr  WC, Iyer  P, Gammon  DW. A dietary risk assessment of the pyrethroid insecticide resmethrin associated with its use for West Nile virus mosquito vector control in California. ScientificWorldJournal. 2006;6:279–90. DOIPubMedGoogle Scholar
  34. New York City Department of Health. Adult mosquito control programs: environmental impact statement (EIS). New York: The Department; 2001 [cited 2009 Mar 1]. http://www.nyc.gov/html/doh/html/wnv/feis.shtml

Main Article

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external